| Feb 19, 2026 |
Feb 23, 2026 |
CAGNONI PABLO J
|
President |
Sell |
17.5
|
-18,668
|
-7.37%
|
✗
|
$1.9M |
| Feb 2, 2026 |
Feb 4, 2026 |
Morrissey Michael James
|
EVP, Head of Tech. Operations |
Sell |
48.8
|
-185
|
-0.54%
|
✗
|
$19K |
| Feb 2, 2026 |
Feb 4, 2026 |
Heeson Lee
|
EVP, Head of Incyte Intl |
Sell |
51.3
|
-111
|
-0.29%
|
✗
|
$11.4K |
| Jan 16, 2026 |
Jan 21, 2026 |
Heeson Lee
|
EVP, Head of Incyte Intl |
Neutral |
90.0
|
+8,911
|
30.47%
|
✗
|
- |
| Jan 16, 2026 |
Jan 21, 2026 |
CAGNONI PABLO J
|
President |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 16, 2026 |
Jan 21, 2026 |
Stein Steven H
|
EVP & Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 16, 2026 |
Jan 21, 2026 |
Issa Mohamed Khairie
|
EVP, Head of US Oncology |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 16, 2026 |
Jan 21, 2026 |
Trotta Matteo
|
EVP, GM, Dermatology US |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 16, 2026 |
Jan 21, 2026 |
Tray Thomas
|
Principal Accounting Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 16, 2026 |
Jan 21, 2026 |
Mayes Patrick A
|
EVP & Chief Scientific Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 16, 2026 |
Jan 21, 2026 |
Morrissey Michael James
|
EVP, Head of Tech. Operations |
Sell |
91.3
|
+6,997
|
25.67%
|
✗
|
$44K |
| Jan 6, 2026 |
Jan 8, 2026 |
Issa Mohamed Khairie
|
EVP, Head of US Oncology |
Sell |
37.5
|
-19,120
|
-22.43%
|
✗
|
$2.1M |
| Jan 5, 2026 |
Jan 7, 2026 |
Stein Steven H
|
EVP & Chief Medical Officer |
Sell |
17.5
|
-15,634
|
-31.37%
|
✗
|
$1.6M |
| Dec 31, 2025 |
Jan 5, 2026 |
Clancy Paul J
|
Director |
Neutral |
77.5
|
+241
|
1.04%
|
✓
|
- |
| Dec 31, 2025 |
Jan 5, 2026 |
HARRIGAN EDMUND
|
Director |
Neutral |
77.5
|
+245
|
1.19%
|
✓
|
- |
| Dec 31, 2025 |
Jan 5, 2026 |
Stein Steven H
|
EVP & Chief Medical Officer |
Sell |
37.5
|
-13,292
|
-21.06%
|
✗
|
$1.3M |
| Dec 31, 2025 |
Jan 5, 2026 |
Morrissey Michael James
|
EVP, Head of Tech. Operations |
Sell |
48.8
|
-254
|
-0.92%
|
✗
|
$25.1K |
| Dec 31, 2025 |
Jan 5, 2026 |
BAKER BROS. ADVISORS LP
|
Director |
Neutral |
47.5
|
+656
|
0.00%
|
✗
|
- |
| Dec 18, 2025 |
Dec 22, 2025 |
Tray Thomas
|
Principal Accounting Officer |
Sell |
20.0
|
-3,374
|
-6.84%
|
✗
|
$336.4K |
| Dec 16, 2025 |
Dec 18, 2025 |
Morrissey Michael James
|
EVP, Head of Tech. Operations |
Sell |
16.3
|
-58,331
|
-67.95%
|
✗
|
$5.7M |
| Dec 10, 2025 |
Dec 12, 2025 |
Mayes Patrick A
|
EVP & Chief Scientific Officer |
Sell |
20.0
|
-5,808
|
-8.82%
|
✗
|
$555K |
| Dec 8, 2025 |
Dec 10, 2025 |
Hoppenot Herve
|
Director |
Sell |
42.5
|
-2,843
|
-0.86%
|
✗
|
$274.9K |
| Dec 1, 2025 |
Dec 3, 2025 |
Stein Steven H
|
EVP & Chief Medical Officer |
Sell |
37.5
|
-39,757
|
-38.64%
|
✗
|
$4.1M |
| Dec 1, 2025 |
Dec 3, 2025 |
Morrissey Michael James
|
EVP, Head of Tech. Operations |
Sell |
51.3
|
-326
|
-0.38%
|
✗
|
$33.3K |
| Dec 1, 2025 |
Dec 3, 2025 |
Hoffman Richard A.
|
EVP & General Counsel |
Neutral |
90.0
|
+9,466
|
100.00%
|
✗
|
- |
|
Dec 3, 2025 |
Hoffman Richard A.
|
EVP & General Counsel |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Nov 21, 2025 |
Nov 25, 2025 |
Tray Thomas
|
Principal Accounting Officer |
Sell |
22.5
|
-769
|
-3.16%
|
✗
|
$79K |
| Nov 17, 2025 |
Nov 19, 2025 |
Denton Sheila A.
|
EVP & General Counsel |
Sell |
26.3
|
-278
|
-1.04%
|
✗
|
$29K |
| Nov 10, 2025 |
Nov 12, 2025 |
Hoppenot Herve
|
Director |
Sell |
15.0
|
-187,500
|
-36.26%
|
✗
|
$19.8M |
| Nov 5, 2025 |
Nov 7, 2025 |
Stein Steven H
|
EVP & Chief Medical Officer |
Sell |
20.0
|
-5,233
|
-4.84%
|
✗
|
$534.8K |
| Nov 4, 2025 |
Nov 6, 2025 |
Denton Sheila A.
|
EVP & General Counsel |
Sell |
22.5
|
-598
|
-2.20%
|
✗
|
$60.6K |
| Nov 3, 2025 |
Nov 5, 2025 |
Heeson Lee
|
EVP, Head of Incyte Intl |
Sell |
20.0
|
-3,074
|
-9.51%
|
✗
|
$289K |
| Oct 15, 2025 |
Oct 17, 2025 |
Denton Sheila A.
|
EVP & General Counsel |
Sell |
26.3
|
-277
|
-1.03%
|
✗
|
$23.6K |
| Oct 2, 2025 |
Oct 6, 2025 |
Denton Sheila A.
|
EVP & General Counsel |
Sell |
40.0
|
-7,230
|
-21.39%
|
✗
|
$622K |
| Oct 1, 2025 |
Oct 3, 2025 |
Mayes Patrick A
|
EVP & Chief Scientific Officer |
Sell |
42.5
|
-1,569
|
-2.33%
|
✗
|
$136K |
| Oct 1, 2025 |
Oct 3, 2025 |
Heeson Lee
|
EVP, Head of Incyte Intl |
Sell |
46.3
|
-463
|
-1.41%
|
✗
|
$40.1K |
| Sep 30, 2025 |
Oct 2, 2025 |
BAKER BROS. ADVISORS LP
|
Director |
Neutral |
47.5
|
+776
|
0.00%
|
✗
|
- |
| Sep 30, 2025 |
Oct 2, 2025 |
Clancy Paul J
|
Director |
Neutral |
77.5
|
+285
|
1.24%
|
✓
|
- |
| Sep 30, 2025 |
Oct 2, 2025 |
HARRIGAN EDMUND
|
Director |
Neutral |
77.5
|
+289
|
1.42%
|
✓
|
- |
| Sep 22, 2025 |
Sep 24, 2025 |
Gardner David H
|
EVP, Chief Strategy Officer |
Neutral |
90.0
|
+9,429
|
100.00%
|
✗
|
- |
|
Sep 24, 2025 |
Gardner David H
|
EVP, Chief Strategy Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 16, 2025 |
Sep 18, 2025 |
Denton Sheila A.
|
EVP & General Counsel |
Sell |
36.3
|
-278
|
-0.83%
|
✗
|
$23.1K |
| Sep 2, 2025 |
Sep 4, 2025 |
Denton Sheila A.
|
EVP & General Counsel |
Sell |
22.5
|
-598
|
-1.77%
|
✗
|
$50.8K |
| Aug 25, 2025 |
Aug 27, 2025 |
Basi Ramitpal K
|
EVP, Human Resources |
Neutral |
90.0
|
+6,506
|
100.00%
|
✗
|
- |
|
Aug 27, 2025 |
Basi Ramitpal K
|
EVP, Human Resources |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 15, 2025 |
Aug 19, 2025 |
Denton Sheila A.
|
EVP & General Counsel |
Sell |
36.3
|
-277
|
-0.83%
|
✗
|
$24K |
| Aug 4, 2025 |
Aug 6, 2025 |
Denton Sheila A.
|
EVP & General Counsel |
Sell |
26.3
|
-598
|
-1.77%
|
✗
|
$45.3K |
|
Aug 5, 2025 |
Mayes Patrick A
|
EVP & Chief Scientific Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 21, 2025 |
Jul 23, 2025 |
Stein Steven H
|
EVP & Chief Medical Officer |
Sell |
20.0
|
-3,706
|
-3.48%
|
✗
|
$251.8K |
| Jul 16, 2025 |
Jul 17, 2025 |
Flannelly Barry P
|
EVP & General Manager US |
Sell |
22.5
|
-1,340
|
-3.67%
|
✗
|
$91.6K |
| Jul 16, 2025 |
Jul 17, 2025 |
Iyengar Vijay K
|
EVP, GMAPPS |
Sell |
22.5
|
-983
|
-2.37%
|
✗
|
$67.2K |
| Jul 15, 2025 |
Jul 17, 2025 |
Denton Sheila A.
|
EVP & General Counsel |
Sell |
97.5
|
+3,366
|
11.28%
|
✗
|
$334.3K |
| Jul 15, 2025 |
Jul 17, 2025 |
Issa Mohamed Khairie
|
EVP, Head of US Oncology |
Neutral |
90.0
|
+8,769
|
11.47%
|
✗
|
- |
| Jul 15, 2025 |
Jul 17, 2025 |
Trotta Matteo
|
EVP, GM, Dermatology US |
Sell |
91.3
|
+5,079
|
51.11%
|
✗
|
$12.4K |
| Jul 15, 2025 |
Jul 17, 2025 |
Heeson Lee
|
EVP, Head of Incyte Intl |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 15, 2025 |
Jul 17, 2025 |
Morrissey Michael James
|
EVP, Head of Tech. Operations |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 14, 2025 |
Jul 16, 2025 |
CAGNONI PABLO J
|
President |
Sell |
92.5
|
+13,630
|
6.16%
|
✗
|
$268.9K |
| Jul 14, 2025 |
Jul 16, 2025 |
Stein Steven H
|
EVP & Chief Medical Officer |
Sell |
37.5
|
-5,826
|
-5.18%
|
✗
|
$1.2M |
| Jul 14, 2025 |
Jul 16, 2025 |
SWAIN PAULA J
|
EVP, Human Resources |
Sell |
90.0
|
+5,423
|
5.37%
|
✗
|
$69.5K |
| Jul 14, 2025 |
Jul 16, 2025 |
Stamoulis Christiana
|
CFO |
Sell |
90.0
|
+8,255
|
7.03%
|
✗
|
$197.1K |
| Jul 14, 2025 |
Jul 16, 2025 |
Tray Thomas
|
Principal Accounting Officer |
Sell |
95.0
|
+3,207
|
15.19%
|
✗
|
$88.2K |
| Jul 14, 2025 |
Jul 16, 2025 |
Iyengar Vijay K
|
EVP, GMAPPS |
Sell |
95.0
|
+3,822
|
10.14%
|
✗
|
$180.9K |
| Jul 14, 2025 |
Jul 16, 2025 |
Flannelly Barry P
|
EVP & General Manager US |
Sell |
42.5
|
-3,255
|
-8.19%
|
✗
|
$225.7K |
| Jul 14, 2025 |
Jul 16, 2025 |
Hoppenot Herve
|
CEO |
Sell |
40.0
|
-9,674
|
-1.84%
|
✗
|
$668.8K |
| Jul 2, 2025 |
Jul 7, 2025 |
SWAIN PAULA J
|
EVP, Human Resources |
Sell |
40.0
|
-6,285
|
-5.86%
|
✗
|
$428.4K |
| Jul 2, 2025 |
Jul 7, 2025 |
Tray Thomas
|
Principal Accounting Officer |
Sell |
42.5
|
-897
|
-4.08%
|
✗
|
$61.1K |
| Jul 2, 2025 |
Jul 7, 2025 |
Stein Steven H
|
EVP & Chief Medical Officer |
Sell |
40.0
|
-12,714
|
-10.16%
|
✗
|
$866.7K |
| Jul 2, 2025 |
Jul 7, 2025 |
Stamoulis Christiana
|
CFO |
Sell |
40.0
|
-11,589
|
-8.98%
|
✗
|
$790K |
| Jul 2, 2025 |
Jul 7, 2025 |
Flannelly Barry P
|
EVP & General Manager US |
Sell |
37.5
|
-19,958
|
-33.43%
|
✗
|
$1.4M |
| Jul 2, 2025 |
Jul 7, 2025 |
Denton Sheila A.
|
EVP & General Counsel |
Sell |
26.3
|
-599
|
-2.21%
|
✗
|
$41.1K |
| Jul 2, 2025 |
Jul 7, 2025 |
Iyengar Vijay K
|
EVP, GMAPPS |
Sell |
37.5
|
-15,426
|
-29.04%
|
✗
|
$1.1M |
| Jul 2, 2025 |
Jul 7, 2025 |
Hoppenot Herve
|
CEO |
Sell |
37.5
|
-42,769
|
-7.51%
|
✗
|
$2.9M |
| Jun 30, 2025 |
Jul 2, 2025 |
BAKER BROS. ADVISORS LP
|
Director |
Neutral |
47.5
|
+984
|
0.00%
|
✗
|
- |
| Jun 30, 2025 |
Jul 2, 2025 |
Clancy Paul J
|
Director |
Neutral |
77.5
|
+361
|
1.60%
|
✓
|
- |
| Jun 30, 2025 |
Jul 2, 2025 |
HARRIGAN EDMUND
|
Director |
Neutral |
77.5
|
+367
|
1.84%
|
✓
|
- |
| Jun 30, 2025 |
Jul 2, 2025 |
Issa Mohamed Khairie
|
EVP, Head of US Oncology |
Neutral |
90.0
|
+27,812
|
57.14%
|
✗
|
- |
| Jul 2, 2025 |
Jul 2, 2025 |
Meury William
|
CEO |
Neutral |
90.0
|
+36,101
|
100.00%
|
✗
|
- |
| Jun 26, 2025 |
Jun 30, 2025 |
Meury William
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jun 30, 2025 |
Meury William
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 26, 2025 |
Jun 30, 2025 |
Hoppenot Herve
|
CEO |
Neutral |
77.5
|
+6,016
|
1.07%
|
✗
|
- |
| Jun 10, 2025 |
Jun 12, 2025 |
BRAWLEY OTIS W
|
Director |
Neutral |
90.0
|
+2,518
|
28.83%
|
✗
|
- |
| Jun 10, 2025 |
Jun 12, 2025 |
FOUSE JACQUALYN A
|
Director |
Neutral |
90.0
|
+2,518
|
14.98%
|
✗
|
- |
| Jun 10, 2025 |
Jun 12, 2025 |
BIENAIME JEAN JACQUES
|
Director |
Neutral |
90.0
|
+2,518
|
13.74%
|
✗
|
- |
| Jun 10, 2025 |
Jun 12, 2025 |
High Katherine A
|
Director |
Neutral |
90.0
|
+2,518
|
23.27%
|
✗
|
- |
| Jun 10, 2025 |
Jun 12, 2025 |
BAKER BROS. ADVISORS LP
|
Director |
Neutral |
47.5
|
+5,036
|
0.02%
|
✗
|
- |
| Jun 10, 2025 |
Jun 12, 2025 |
Clancy Paul J
|
Director |
Neutral |
90.0
|
+2,518
|
12.55%
|
✗
|
- |
| Jun 10, 2025 |
Jun 12, 2025 |
Schaffert Susanne
|
Director |
Sell |
95.0
|
+1,669
|
29.18%
|
✗
|
$59.5K |
| Jun 10, 2025 |
Jun 12, 2025 |
HARRIGAN EDMUND
|
Director |
Neutral |
90.0
|
+2,518
|
14.44%
|
✗
|
- |
| Jun 3, 2025 |
Jun 5, 2025 |
Denton Sheila A.
|
EVP & General Counsel |
Sell |
22.5
|
-1,795
|
-6.34%
|
✗
|
$122.1K |
| May 30, 2025 |
Jun 3, 2025 |
Tray Thomas
|
Principal Accounting Officer |
Sell |
22.5
|
-1,614
|
-6.83%
|
✗
|
$105.5K |
| Apr 1, 2025 |
Apr 3, 2025 |
Flannelly Barry P
|
EVP & General Manager US |
Neutral |
90.0
|
+26,135
|
77.86%
|
✗
|
- |
| Apr 1, 2025 |
Apr 3, 2025 |
Iyengar Vijay K
|
EVP, GMAPPS |
Neutral |
90.0
|
+22,141
|
72.22%
|
✗
|
- |
| Apr 1, 2025 |
Apr 3, 2025 |
Morrissey Michael James
|
EVP, Head of Tech. Operations |
Neutral |
85.0
|
+4,649
|
5.70%
|
✗
|
- |
| Apr 1, 2025 |
Apr 3, 2025 |
Stamoulis Christiana
|
CFO |
Neutral |
90.0
|
+37,568
|
41.05%
|
✗
|
- |
| Apr 1, 2025 |
Apr 3, 2025 |
Stein Steven H
|
EVP & Chief Medical Officer |
Neutral |
90.0
|
+58,165
|
86.86%
|
✗
|
- |
| Apr 1, 2025 |
Apr 3, 2025 |
SWAIN PAULA J
|
EVP, Human Resources |
Neutral |
90.0
|
+22,141
|
25.99%
|
✗
|
- |
| Apr 1, 2025 |
Apr 3, 2025 |
Hoppenot Herve
|
CEO |
Neutral |
90.0
|
+66,899
|
13.47%
|
✗
|
- |
| Mar 31, 2025 |
Apr 2, 2025 |
BAKER BROS. ADVISORS LP
|
Director |
Neutral |
47.5
|
+974
|
0.00%
|
✗
|
- |
| Mar 31, 2025 |
Apr 2, 2025 |
Clancy Paul J
|
Director |
Neutral |
77.5
|
+358
|
1.82%
|
✓
|
- |
| Mar 31, 2025 |
Apr 2, 2025 |
HARRIGAN EDMUND
|
Director |
Neutral |
77.5
|
+363
|
2.13%
|
✓
|
- |